1. Repository of OAI
Ελληνικά   English  

Browsing by Author Elisaf, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 20 to 39 of 87 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Beneficial effect of L-thyroxine on HDL-associated PAF-acetylhydrolase in patients with subclinical hypothyroidismMilionis, H.; Tambaki, A.; Kanioglou, C.; Tsatsoulis, A.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Cholesterol Efflux from Macrophages Induced by High Density Lipoprotein Subclasses and Total SerumKazakou, P.; Petraki, M.; Elisaf, M.; Tselepis, A.24-Nov-2015-
Clinical significance of the atorvastatin-clopidogrel drug-drug interaction - ResponseMitsios, J. V.; Papathanasiou, A. I.; Rodis, F. I.; Elisaf, M.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuriaKarabina, S. A.; Pappas, H.; Miltiadous, G.; Bairaktari, E.; Christides, D.; Tselepis, A.; Elisaf, M.; Siamopoulos, K.24-Nov-2015-
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteriaGazi, I.; Tsimihodimos, V.; Filippatos, T.; Bairaktari, E.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Correlation of autoantibody titers against various forms of oxidized LDL with carotid intima media thickness (IMT) in hyperlipidemic patientsKiortsis, D.; Tsouli, S.; Xydis, V.; Lourida, E.; Argyropoulou, M.; Efremidis, S.; Evangelou, A.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A(2)Saougos, V. G.; Tambaki, A. P.; Kalogirou, M.; Kostapanos, M.; Gazi, I. F.; Wolfert, R. L.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of Ezetimibe on Lipoprotein Subfraction Concentrations: The Role of Atorvastatin PretreatmentTsimihodimos, V.; Kalogirou, M.; Lagos, K.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemiasKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on LDL subfractions in patients with combined dyslipidemiaTsimihodimos, V.; Irene, G.; Tselepis, A.; Bairaktari, E.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride valuesTsimihodimos, V.; Kostoula, A.; Tzavaras, V.; Kalogirou, M.; Bairaktari, E.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride valuesTsimihodimos, V.; Kostoula, A.; Kakafika, A.; Bairaktari, E.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
The effect of hypolipidaemic agents on lipoprotein-associated phospholipase A2 (Lp-PLA2)Saougos, V.; Filippatos, T.; Kostapanos, M.; Kalogirou, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
The effect of hypolipidaemic drugs on lipoprotein- associated phospholipase A2 (Lp-PLA2) activity and massSaougos, V.; Kostapanos, M.; Kalogirou, M.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetyllhydrolaseTsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
The Effect of Nicotinic Acid/Laropiprant Administration on the Lipoprotein-Associated Phospholipase A2 (Lp-Pla2) Activity in Patients with Mixed DyslipidemiaKei, A.; Liberopoulos, E.; Tellis, K.; Rizos, C.; Tselepis, A.; Elisaf, M.24-Nov-2015-
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Tambaki, A. P.; Abatzis, M.; Biris, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Soteriadou, K.; Goudevenos, J.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Effects of anithypertensive and hypolipidemic drugs on plasma and lipoprotein-associated PAF-acetylhydrolaseTsimihodimos, V.; Tambaki, A.; Rizos, E.; Tselepis, A.; Siamopoulos, K.; Elisaf, M.24-Nov-2015-
Showing results 20 to 39 of 87 < previous   next >